Latest News about ILMN
Recent news which mentions ILMN
10 Biggest Price Target Changes For Tuesday
February 16, 2021
From Benzinga
64 Biggest Movers From Friday
February 16, 2021
From Benzinga
Why These 2 Hot Nasdaq Stocks Are Soaring Friday
February 12, 2021
From Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
February 12, 2021
From Benzinga
Why Illumina Stock Is Skyrocketing Today
February 12, 2021
From Motley Fool
Illumina Inc (ILMN) Q4 2020 Earnings Call Transcript
February 11, 2021
Tickers
ILMN
From Motley Fool
16 Stocks Moving In Thursday's After-Hours Session
February 11, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
Earnings Scheduled For February 11, 2021
February 11, 2021
From Benzinga
Why Pacific Biosciences of California Stock Is Soaring Today
February 10, 2021
From Motley Fool
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
Vaccines Are Still Protecting Against the Coronavirus Variants (for Now)
February 08, 2021
From Motley Fool
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
February 06, 2021
From Benzinga
Is Pacific Biosciences of California a Ticking Time Bomb for Investors?
February 02, 2021
From Motley Fool
2 Stocks That Wall Street Hates but You'll Probably Like
February 01, 2021
From Motley Fool
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
January 29, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 28, 2021
From Benzinga
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO
January 28, 2021
From Benzinga
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
From Benzinga
From Benzinga
From Benzinga
The new B.1.1.7 is a ‘super-spreader’ strain. Here’s how the U.S. can control it, says Dr. Eric Topol
January 20, 2021
From MarketWatch
'Fast Money' Picks For January 19
January 17, 2021
From Benzinga
Fear of new virus variant pushes U.S. toward more genomic sequencing
January 15, 2021
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.